AptarGroup stock update, consensus and valuation picture for ATR shares

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 19:57.

AptarGroup Inc. (US0383361039) sits in the analyst spotlight at the start of the week, with a broadly positive consensus on the NYSE-listed packaging stock. The current focus is on valuation multiples and recent target price updates from Wall Street houses.

How analysts rate AptarGroup

Consensus data compiled by MarketScreener shows that a majority of analysts covering AptarGroup rate the stock either Buy or Outperform, with a smaller group on Hold and virtually no active Sell recommendations. The picture reflects the company’s relatively defensive positioning in consumer and healthcare packaging. MarketScreener consensus on AptarGroup

Price targets cluster moderately above the current share price, pointing to limited but positive upside in the mid single-digit to low double-digit percent range according to the aggregated data. The dispersion between the highest and lowest targets remains contained, which suggests that the analyst community sees AptarGroup as a stable mid-cap rather than a high-beta cyclical name.

Valuation versus global peers

On the NYSE AptarGroup trades in the wider packaging and dispensing peer group that includes names such as WestRock, Ball and Crown Holdings. Based on recent data from MarketWatch, AptarGroup’s forward price-to-earnings multiple is higher than some commodity-exposed packaging peers but closer to premium healthcare packaging names, which investors often treat as quality defensives. MarketWatch valuation snapshot for ATR

The valuation premium reflects AptarGroup’s mix exposure to personal care, beauty and prescription drug packaging, segments that tend to deliver steadier margins and recurring demand. In this context, the shares’ current level incorporates expectations for continued earnings growth but not a major cyclical upswing, consistent with the analyst consensus.

What AptarGroup sells

AptarGroup generates most of its revenue from dispensing and packaging solutions for consumer goods and healthcare, including pumps and closures used in beauty, personal care and pharmaceuticals. The group’s technologies aim to provide precise dosing, product protection and convenience for global brand owners.

Where the stock trades today

As of 2026-06-29, 17:30, AptarGroup shares trade on the NYSE under the ticker ATR at around 135.00 US dollars.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.